Detalhe da pesquisa
1.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060001
2.
Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome.
Haematologica
; 106(12): 3034-3045, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407607
3.
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
Am J Hematol
; 96(11): 1472-1480, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424575
4.
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
Br J Haematol
; 191(2): 207-211, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32679621
5.
Morphological anomalies of circulating blood cells in COVID-19.
Am J Hematol
; 95(7): 870-872, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279346
6.
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.
Blood Cancer J
; 12(2): 28, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145055
7.
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.
Blood Cancer J
; 11(12): 199, 2021 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897288